LUND, Sweden, November 4, 2024 – Cellevate is excited to announce its commercial launch of the world’s first nanofiber-based cell culture systems for viral vector production. The official global launch of Cellevat3d® nanofiber-based cell culture systems will take place at BIO-Europe in Stockholm, Sweden, on November 4-6, 2024. Join our launch event and company presentation on November 5 at 13:45 in Room K12 and visit us at booth #138.
Cellevat3d® nanofiber-based cell culture systems represent a potential paradigm shift in upstream bioprocessing, with up to 60 times larger surface area for cell growth than current solutions. The nanofibers create a true three-dimensional cell culture environment, significantly increasing cell densities, viral vector yields and productivity in stirred tank bioreactors. Furthermore, Cellevat3d® nanofiber cell culture systems are easy to use and easy to scale from lab to large scale bioreactors.
“The launch and commercialization of Cellevate´s first industrial product, Cellevat3d® nanofiber-based cell culture systems, represent a fantastic milestone for the company and an amazing achievement for the Cellevate team. In less than three years we have developed, validated, produced, and are now starting to commercialize this breakthrough innovation in viral vector production. By implementing this completely new category of sustainable cell culture systems in process development, benchmarking data show that we can achieve more than three times the viral vector yield, faster and more efficient scale-up in bioreactors, and a decrease in production costs. Our mission is to accelerate the biomanufacturing revolution to make cell and gene therapies and novel vaccines more accessible to patients,” said Laura Chirica, CEO, Cellevate
For more information about our innovative Cellevat3d® nanofiber-based cell culture systems, to place an order or to connect with Cellevate representatives, please visit Cellevate’s updated website.
For more information, please contact:
Laura Chirica, PhD
CEO Cellevate
Email: laura.chirica@cellevate.com
About Cellevate
Cellevate is a Swedish biotech company based on proprietary nanofiber technology dedicated to building the next generation cell culture systems for cell- and gene therapy and novel vaccines biomanufacturing. The core nanotechnology, Cellevat3d® is a sustainable, deep-tech innovation for the biopharmaceutical industry. This platform allows for an industrial-scale production of a new category of nanofiber cell culture systems – with unparalleled surface area for cell growth, reproducibility, customization, and scalability, which ultimately lead to increased productivity and process economy. Cellevat3d® nanofiber-based products are designed as an integrated part of upstream bioprocessing solutions, from laboratory to large-scale batch production.
For more information, please visit Cellevate’s updated website.